GAGNON ADVISORS LLC
Q4 2025 Form 13-F

NEW YORK, NEW YORK
CIK 0001599466 · CRD 161697 · SEC-registered investment adviser
$157.5M Reported Value Total

GAGNON ADVISORS reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $187,307,870, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
4 funds · $307.0M gross asset value
Hedge Fund: $307.0M
Source: Form ADV filed 2026-08-12
Reported value
$157.5M
Quarter over quarter
-0.2%
Holdings
23
Top-10 concentration
65.3%

Key People

Form ADV owners & control persons
Neil Joseph Gagnon
CHIEF EXECUTIVE OFFICER
Maureen Oneill Drew
MEMBER
Brian Joseph Gagnon
MEMBER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2025 13F record

Q4 2025 13F filing summary

Q4 2025 Form 13F portfolio summary
Period of report December 31, 2025
Filed February 13, 2026
Form 13F-HR
Reported value $157.5M
Positions 23
Change in reported value -2.7%
New positions 0
Exited positions 1
Position turnover 4.2%
Top-10 concentration 65.3%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 5, 2026
24 $182.1M
Q2 2026 13F
Filed Aug 5, 2026
22 $151.1M
Q1 2026 13F
Filed Apr 22, 2026
22 $135.9M
Q4 2025 13F
Filed Feb 13, 2026
23 $157.5M
Q3 2025 13F
Filed Nov 3, 2025
24 $162.0M
Q2 2025 13F
Filed Jul 23, 2025
24 $148.8M
Q1 2025 13F
Filed May 12, 2025
28 $141.8M
Q4 2024 13F
Filed Jan 24, 2025
26 $156.2M
Q3 2024 13F
Filed Nov 12, 2024
27 $154.8M
Q2 2024 13F
Filed Aug 14, 2024
27 $131.3M
Q1 2024 13F
Filed May 13, 2024
27 $115.3M
Q4 2023 13F
Filed Feb 14, 2024
26 $114.5M
Q3 2023 13F
Filed Nov 14, 2023
28 $119.5M
Q2 2023 13F
Filed Aug 8, 2023
29 $149.4M
Q1 2023 13F
Filed Apr 10, 2023
28 $149.0M
Q4 2022 13F
Filed Feb 7, 2023
29 $148.2M
Q3 2022 13F
Filed Nov 14, 2022
32 $154.4M
Q2 2022 13F
Filed Aug 1, 2022
33 $165.1M
Q1 2022 13F
Filed May 9, 2022
33 $217.1M
Q4 2021 13F
Filed Feb 8, 2022
34 $251.7M

32 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2025

Largest Q4 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 WGS GENEDX HOLDINGS CORP $16.5M 10.49%
2 AMRC AMERESCO INC $13.8M 8.79%
3 AL AIR LEASE CORP $12.6M 8.01%
4 EPD ENTERPRISE PRODS PARTNERS L P $10.9M 6.92%
5 CDNA CAREDX INC $10.0M 6.37%
6 NVGS NAVIGATOR HLDGS LTD $9.0M 5.69%
7 EQIX EQUINIX INC $8.2M 5.21%
8 PROF PROFOUND MED CORP $7.6M 4.81%
9 BL BLACKLINE INC $7.2M 4.56%
10 FRSH FRESHWORKS INC $6.9M 4.39%
11 PCRX PACIRA BIOSCIENCES INC $6.8M 4.29%
12 FIVN FIVE9 INC $6.7M 4.28%
13 BLFS BIOLIFE SOLUTIONS INC $6.6M 4.21%
14 AMPL AMPLITUDE INC $5.3M 3.36%
15 DV DOUBLEVERIFY HLDGS INC $5.0M 3.18%
16 HZO MarineMax Inc $4.7M 2.99%
17 VERX VERTEX INC $4.6M 2.95%
18 TMCI TREACE MED CONCEPTS INC $3.8M 2.39%
19 NVDA NVIDIA CORPORATION $3.1M 1.96%
20 OSUR OraSure Technologies Inc $2.9M 1.86%

Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings